Y-Intercept (HK)’s Cardinal Health CAH Stock Holding History

Y-Intercept (HK)’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13M	Buy	13,190 +9,668	+275%	+$2.01M	0.06%	461
2026 Q1	$744K	Buy	+3,522	New	+$758K	0.01%	1136
2025 Q4	–	Sell	-26,613	Closed	-$4.18M	–	1576
2025 Q3	$4.18M	Buy	26,613 +8,877	+50%	+$1.37M	0.1%	266
2025 Q2	$2.98M	Sell	17,736 -21,080	-54%	-$3.13M	0.07%	425
2025 Q1	$5.35M	Buy	38,816 +27,984	+258%	+$3.57M	0.36%	45
2024 Q4	$1.28M	Sell	10,832 -4,371	-29%	-$510K	0.09%	335
2024 Q3	$1.68M	Buy	15,203 +2,015	+15%	+$211K	0.1%	259
2024 Q2	$1.3M	Sell	13,188 -7,328	-36%	-$747K	0.07%	388
2024 Q1	$2.3M	Sell	20,516 -29,883	-59%	-$3.22M	0.17%	141
2023 Q4	$5.08M	Buy	+50,399	New	+$5M	0.47%	14
2023 Q1	–	Sell	-6,676	Closed	-$513K	–	1201
2022 Q4	$513K	Buy	+6,676	New	+$507K	0.08%	422
2022 Q3	–	Sell	-7,366	Closed	-$385K	–	979
2022 Q2	$385K	Sell	7,366 -12,805	-63%	-$728K	0.05%	501
2022 Q1	$1.14M	Sell	20,171 -38,224	-65%	-$2.05M	0.26%	87
2021 Q4	$3.01M	Buy	58,395 +47,687	+445%	+$2.34M	0.71%	15
2021 Q3	$530K	Buy	+10,708	New	+$581K	0.1%	317
2021 Q2	–	Sell	-13,068	Closed	-$814K	–	641
2021 Q1	$814K	Buy	13,068 +5,752	+79%	+$317K	0.22%	136
2020 Q4	$391K	Buy	+7,316	New	+$380K	0.16%	226

Other funds holding CAH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Y-Intercept (HK)'s CAH Position: Q2 2026 in Review

Y-Intercept (HK) increased its Cardinal Health (CAH) stake by 275% in Q2 2026, buying an estimated $2.01M and bringing the position to 13,190 shares worth $3.13M. The position accounts for 0.06% of the portfolio, ranked #461.

Y-Intercept (HK) first reported a position in CAH in Q4 2020 and has held it in 17 quarters since. The position peaked at $5.35M in Q1 2025. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

Y-Intercept (HK) held 13,190 shares of Cardinal Health worth $3.13M as of Q2 2026.
Y-Intercept (HK) bought 9,668 Cardinal Health shares in Q2 2026, an estimated $2.01M.
Cardinal Health made up 0.06% of Y-Intercept (HK)'s portfolio in Q2 2026, its #461 holding.
Y-Intercept (HK) first reported a position in Cardinal Health in Q4 2020 and has held it in 17 quarters since.
Y-Intercept (HK)'s Cardinal Health position peaked at $5.35M in Q1 2025.
1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.